News & Events

Learn more about ReForm Biologics and our commitment to innovation in biotherapeutics.

BioProcess International Conference – September 25-28, 2017

ReForm Biologics will present a talk entitled “A Novel Excipient for High-Concentration Protein Formulations”  in the “Drug Product, Fill-Finish & Formulations” track at BioProcess International Conference on September 28th at the Hynes Convention Center in Boston.  Conference details are available at:

The Bioprocessing Summit – August 21-25, 2017

ReForm Biologics will present a poster with details of a new excipient study for surfactant replacement in the “Overcoming Formulation Challenges for Biopharmaceutical Development” track at The Bioprocessing Summit, taking place August 21-25, 2017 at the Westin Copley Place in Boston.  Conference details are available at:

ReForm Biologics Announces Issuance of U.S. Patent for New Excipient to Improve Antibody-Based Therapeutics

ReForm Biologics to present at the 13th annual PEGS Summit

ReForm Biologics, a pharmaceutical technology company developing an innovative platform to improve biologic formulations, announced today the issuance of U.S. patent 9,605,051 (the ‘051 patent) for one of its new excipient formulations.

Read More >

ReForm Biologics Appoints John M. Sorvillo, Ph.D., as Chief Executive Officer

Dr. Sorvillo brings over 25 years of experience leading the development and licensing of technologies, from discovery platforms and research programs to pre-clinical and clinical products, across a range of therapeutic areas.

Read More >